Consolidated Portfolio Review Corp Increases Stock Holdings in Lam Research Corporation $LRCX

Key Points

• Consolidated Portfolio Review Corp increased its stake in Lam Research Corporation ($LRCX) by 10.6%, owning 24,246 shares valued at $2.36 million as of the latest reporting period.
• Analysts have raised price targets for Lam Research, with a consensus average target now at $115.33 and a strong majority rating it as a "Buy."
• Lam Research also announced a quarterly dividend increase from $0.23 to $0.26, representing a 0.8% dividend yield for shareholders.

Consolidated Portfolio Review Corp boosted its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 10.6% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,246 shares of the semiconductor company's stock after acquiring an additional 2,316 shares during the quarter. Consolidated Portfolio Review Corp's holdings in Lam Research were worth $2,360,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of Lam Research by 6.9% during the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company's stock worth $9,389,358,000 after purchasing an additional 8,364,375 shares in the last quarter. Invesco Ltd. grew its holdings in Lam Research by 2.8% during the 1st quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company's stock valued at $1,259,947,000 after purchasing an additional 472,636 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Lam Research by 25.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 9,536,708 shares of the semiconductor company's stock worth $693,319,000 after buying an additional 1,953,221 shares during the period. Charles Schwab Investment Management Inc. increased its stake in Lam Research by 4.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 8,900,506 shares of the semiconductor company's stock worth $647,067,000 after buying an additional 418,077 shares during the period. Finally, Nuveen LLC acquired a new position in Lam Research in the 1st quarter worth $604,344,000. Institutional investors and hedge funds own 84.61% of the company's stock.

Analysts Set New Price Targets

LRCX has been the subject of several recent analyst reports. Needham & Company LLC raised their target price on Lam Research from $110.00 to $115.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. UBS Group raised their price objective on Lam Research from $95.00 to $120.00 and gave the company a "buy" rating in a research note on Monday, July 21st. Wells Fargo & Company set a $98.00 price objective on Lam Research and gave the stock an "equal weight" rating in a report on Thursday, July 31st. B. Riley increased their target price on Lam Research from $130.00 to $160.00 and gave the company a "buy" rating in a research note on Wednesday, September 24th. Finally, Raymond James Financial lifted their price target on shares of Lam Research from $90.00 to $110.00 and gave the stock an "outperform" rating in a research note on Thursday, July 31st. Twenty-one research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $115.33.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $133.90 on Wednesday. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $168.85 billion, a price-to-earnings ratio of 32.19, a price-to-earnings-growth ratio of 1.65 and a beta of 1.76. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $134.21. The business has a 50 day simple moving average of $107.60 and a 200-day simple moving average of $90.97.

Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. During the same period last year, the business posted $1.03 earnings per share. The firm's revenue for the quarter was up 33.6% on a year-over-year basis. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, September 24th will be issued a $0.26 dividend. This is a boost from Lam Research's previous quarterly dividend of $0.23. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 annualized dividend and a dividend yield of 0.8%. Lam Research's dividend payout ratio (DPR) is presently 25.00%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.